Pfizer
Patents, Design & Utilities
Last updated:
List of all Pfizer patents 451 in total
| Status | Patent |
|---|---|
Application | Utility: COMBINATION OF A PD-1 ANTAGONIST AND A VEGFR INHIBITOR FOR TREATING CANCER Filling date: 13 Sep 2025 Issue date: 15 Oct 2020 |
Application | Utility: CRYSTALLINE FORMS OF LORLATINIB MALEATE Filling date: 13 Sep 2025 Issue date: 15 Oct 2020 |
Grant | Utility: CDK2/4/6 inhibitors Filling date: 13 Sep 2025 Issue date: 13 Oct 2020 |
Grant | Utility: PD-1/PD-L1 inhibitors for the treatment of cancer Filling date: 13 Sep 2025 Issue date: 13 Oct 2020 |
Grant | Utility: Bicyclic-fused heteroaryl or aryl compounds Filling date: 13 Sep 2025 Issue date: 6 Oct 2020 |
Grant | Utility: Therapeutic antibodies and their uses Filling date: 13 Sep 2025 Issue date: 6 Oct 2020 |
Application | Utility: Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens and Uses Thereof Filling date: 13 Sep 2025 Issue date: 1 Oct 2020 |
Application | Utility: Targeted Therapeutic Nanoparticles And Methods Of Making And Using Same Filling date: 13 Sep 2025 Issue date: 1 Oct 2020 |
Application | Utility: ANTI-IL-33 ANTIBODIES, COMPOSITIONS, METHODS AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 1 Oct 2020 |
Application | Utility: CRYSTALLINE FORM OF LORLATINIB FREE BASE HYDRATE Filling date: 13 Sep 2025 Issue date: 1 Oct 2020 |
Grant | Utility: Substituted 3-azabicyclo[3.1.0]hexanes as ketohexokinase inhibitors Filling date: 13 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: Immunogenic compositions for use in pneumococcal vaccines Filling date: 13 Sep 2025 Issue date: 29 Sep 2020 |
Grant | Utility: Compositions and methods relating to a mutant clostridium difficile toxin Filling date: 13 Sep 2025 Issue date: 29 Sep 2020 |
Application | Utility: SGLT-2 INHIBITORS FOR TREATING METABOLIC DISORDERS IN PATIENTS WITH RENAL IMPAIRMENT OR CHRONIC KIDNEY DISEASE Filling date: 13 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: TREATMENT OF ABNORMAL VISCERAL FAT DEPOSITION USING SOLUBLE FIBROBLAST GROWTH FACTOR RECEPTOR 3 (SFGFR3) POLYPEPTIDES Filling date: 13 Sep 2025 Issue date: 24 Sep 2020 |
Application | Utility: HETEROAROMATIC COMPOUNDS AND THEIR USE AS DOPAMINE D1 LIGANDS Filling date: 13 Sep 2025 Issue date: 10 Sep 2020 |
Application | Utility: ANTIBODIES AND ANTIBODY-DRUG CONJUGATES SPECIFIC FOR CD123 AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 10 Sep 2020 |
Grant | Utility: Cyclin dependent kinase inhibitors Filling date: 13 Sep 2025 Issue date: 8 Sep 2020 |
Application | Utility: ANTAGONIST ANTIBODIES AGAINST GDF-8 AND USES THEREFOR Filling date: 13 Sep 2025 Issue date: 3 Sep 2020 |
Application | Utility: EZH2 INHIBITOR COMBINATION THERAPIES Filling date: 13 Sep 2025 Issue date: 27 Aug 2020 |
Grant | Utility: Immunogenic compositions and uses thereof Filling date: 13 Sep 2025 Issue date: 25 Aug 2020 |
Application | Utility: DIHYDRO-PYRROLO-PYRIDINE DERIVATIVES Filling date: 13 Sep 2025 Issue date: 20 Aug 2020 |
Application | Utility: Therapeutic Particles with Peptide Boronic Acid or Boronate Ester Compounds and Methods of Making and Using Same Filling date: 13 Sep 2025 Issue date: 20 Aug 2020 |
Grant | Utility: Glycoconjugation process Filling date: 13 Sep 2025 Issue date: 18 Aug 2020 |
Application | Utility: GLP-1 RECEPTOR AGONISTS AND USES THEREOF Filling date: 13 Sep 2025 Issue date: 13 Aug 2020 |
Application | Utility: Combination of a PARP Inhibitor and a PD-1 Axis Binding Antagonist Filling date: 13 Sep 2025 Issue date: 13 Aug 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR ELICITING AN IMMUNE RESPONSE AGAINST CLOSTRIDIUM DIFFICILE Filling date: 13 Sep 2025 Issue date: 13 Aug 2020 |
Grant | Utility: 6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-2-carboxamide compounds Filling date: 13 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: Anti-IL-2 antibodies and compositions and uses thereof Filling date: 13 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: Diagnostic anti-PD-L1 antibody and use thereof Filling date: 13 Sep 2025 Issue date: 11 Aug 2020 |
Grant | Utility: Cells having reduced BCAT1 Filling date: 13 Sep 2025 Issue date: 11 Aug 2020 |
Application | Utility: IMMUNOGENIC GLYCOPROTEIN CONJUGATES Filling date: 13 Sep 2025 Issue date: 6 Aug 2020 |
Application | Utility: CDK2 INHIBITORS Filling date: 13 Sep 2025 Issue date: 6 Aug 2020 |
Application | Utility: GLYCOCONJUGATION PROCESSES AND COMPOSITIONS Filling date: 13 Sep 2025 Issue date: 6 Aug 2020 |
Application | Utility: HUMAN CYTOMEGALOVIRUS GB POLYPEPTIDE Filling date: 13 Sep 2025 Issue date: 6 Aug 2020 |
Application | Utility: Immunogenic Compositions for Use in Pneumococcal Vaccines Filling date: 13 Sep 2025 Issue date: 30 Jul 2020 |
Application | Utility: METHOD OF CELL CULTURE Filling date: 13 Sep 2025 Issue date: 30 Jul 2020 |
Grant | Utility: 1,1,1-trifluoro-3-hydroxypropan-2-yl carbamate derivatives and 1,1,1-trifluoro-4-hydroxybutan-2-yl carbamate derivatives as MAGL inhibitors Filling date: 13 Sep 2025 Issue date: 28 Jul 2020 |
Grant | Utility: Solid forms of a selective CDK4/6 inhibitor Filling date: 13 Sep 2025 Issue date: 28 Jul 2020 |
Grant | Utility: Tubulysin analogs and methods for their preparation Filling date: 13 Sep 2025 Issue date: 28 Jul 2020 |
Application | Utility: CAPPED AND UNCAPPED ANTIBODY CYSTEINES, AND THEIR USE IN ANTIBODY-DRUG CONJUGATION Filling date: 13 Sep 2025 Issue date: 23 Jul 2020 |
Grant | Utility: Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2- -methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof Filling date: 13 Sep 2025 Issue date: 14 Jul 2020 |
Grant | Utility: SGLT-2 inhibitors for treating metabolic disorders in patients with renal impairment or chronic kidney disease Filling date: 13 Sep 2025 Issue date: 14 Jul 2020 |
Grant | Utility: Substituted carbonucleoside derivatives useful as anticancer agents Filling date: 13 Sep 2025 Issue date: 14 Jul 2020 |
Grant | Design: Blister pack pill tray Filling date: 13 Sep 2025 Issue date: 7 Jul 2020 |
Grant | Design: Blister pack pill tray Filling date: 13 Sep 2025 Issue date: 7 Jul 2020 |
Grant | Design: Pill blister pack Filling date: 13 Sep 2025 Issue date: 7 Jul 2020 |
Grant | Design: Pill blister pack Filling date: 13 Sep 2025 Issue date: 7 Jul 2020 |
Grant | Utility: Pyrrolo[2,3-D]pyrimidinyl, pyrrolo[2,3-B]pyrazinyl, pyrrolo[2,3-B]pyridinyl acrylamides and epoxides thereof Filling date: 13 Sep 2025 Issue date: 7 Jul 2020 |
Application | Utility: TOFACITINIB ORAL SUSTAINED RELEASE DOSAGE FORMS Filling date: 13 Sep 2025 Issue date: 2 Jul 2020 |
Showing 250 to 300 of 451 patents.